DELRAY BEACH, Fla., Aug. 13, 2013 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the Rodman & Renshaw 15th Annual Global Investment Conference taking place September 9-10, 2013, at the Millennium Broadway Hotel in New York City. The Company's presentation will be posted in the Investors & Media section of its website and will also be available via webcast at: http://wsw.com/webcast/rrshq23/PSID .

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com .

Statements about PositiveID's future expectations constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on April 16, 2013, and 10-Q filed on May 20, 2013, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

 CONTACT: PositiveID Corporation 
 
Allison Tomek 
 
561-805-8000 
 
atomek@positiveidcorp.com